Prognostic factor for medical control for seizures in patients with radiologic evidence for mesial temporal lobe sclerosis;Factores pronósticos asociados al control médico en pacientes con evidencia radiológica de esclerosis mesial temporal

Revista de Neurologia

Volumn 36, Issue 6, 2003, Pages 501-506

  Falip, Mercé ^a,b   Gratacos M ^a   Santamarina, E ^a   Rovira, R ^a   Padro Ll ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE   (Spain)

Author keywords

Drug resistance; Mesial temporal lobe sclerosis; Pharmacological treatment; Prognostic factors

Indexed keywords

ARTICLE; BRAIN ATROPHY; DISEASE DURATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MESIAL TEMPORAL LOBE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PROGNOSIS; SEIZURE; TEMPORAL LOBE EPILEPSY;

EID: 0348112538     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3606.2002492     Document Type: Article

References (27)

1. Mogan RE. Mesial temporal sclerosis. Arch Neurol 2001; 58: 1484-6.
2. Oikawa H, Sasaki M, Tamakawa Y, Kamai A. The circuit of Papez in the mesial temporal lobe sclerosis: MRI. Neurology 2001; 43: 205-10.
3. Wieser HG, Engel J, Willianson PP. Surgically remediable temporal lobe syndromes. In Engel J, ed. Surgical treatment of the epilepsies. New York: Raven Press; 1993. p. 49-63.
4. Gloor P. Mesial temporal sclerosis: historical background and overview from a modern perspective. In Lüders H, ed. Epilepsy surgery. New York: Raven Press; 1991. p. 689-703.
5. Sánchez-Álvarez JC, Pastor-Pons E, García-Gómez T, Escamilla F, Galdón A Busquier H. El diagnóstico de la esclerosis mesial temporal mediante imagen de resonancia magnética. Rev Neurol 2000; 31: 701-11.
6. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Brone AV, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313: 145-51.
7. Kim WJ, Park S, Lee S, Lee J, Kim JY, Lee BY. The prognosis for control of seizures in patients with MRI evidence for mesial temporal lobe sclerosis. Epilepsia 1999; 40: 290-3.
8. Gil-Nagel A. El síndrome de esclerosis mesial temporal en epilepsia. Rev Neurol 1998; 13: 132-44.
9. Cendes F, Andermann F, Dubeau F, Gloor P, Evans A, Jones-Gotman M, et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures and temporal lobe epilepsy: an MRI volumetric study. Neurology 1993; 43: 1083-7.
10. Engel J, Williamson P, Wieser HG. Hippocampal sclerosis. In Engel J, Pedley TA, eds. Epilepsy: the comprehensive CD-Rom. Philadelphia: Lippincott Williams & Wilkins; 1999.
11. Krishnan B, Armstrong DL, Grossman RG, Zhu ZQ, Rutecki PA, Mizrahi EM. Glial cell nuclear hypertrophy in complex partial seizures. J Neuropathol Exp Neurol 1994; 53: 502-7.
12. Mouritzen-Dam A. Epilepsy and neuron loss in the hippocampus. Epilepsia 1980; 21: 617-29.
13. Mathern GW, Babb TL, Vickrey BG, Meléndez M, Pretorius JK. The clinical pathogenic mechanism of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995; 118: 105-13.
14. French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, et al. Characteristics of medial temporal lobe epilepsy. Results of history and physical examination. Ann Neurol 1993; 34: 774-80.
15. King DW, Ajmone-Marsan C. Clinical features and ictal patterns in epileptic patients with EEG temporal lobe foci. Ann Neurol 1993; 34: 774-80.
16. Gloor P. Role of the amygdala in temporal lobe epilepsy. In temporal lobe and limbic system. New York: Oxford University Press; 1997. p. 677-717.
17. Fakhoury T, Abon-Khalil B, Peguera E. Differentiating clinical features of right and left temporal lobe seizures. Epilepsia 1994; 35: 1038-44.
18. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM, et al. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 1992; 115: 1001-15.
19. Fried I, Jung HK, Spencer DD. Hippocampal pathology in patients with intractable seizures and temporal lobe masses. J Neurosurg 1992; 786: 735-40.
20. Jackson GD, Kuzniecky RI, Cascino GD. Hippocampal sclerosis without detectable hippocampal atrophy. Neurology 1994; 44: 42-6.
21. Kuzniecky RI, Burgard S, Bilir E, Morawetz R, Gillian F, Faught E, et al. Qualitative MRI segmentation in mesial temporal sclerosis. Clinical correlations. Epilepsia 1996; 37: 433-9.
22. Van Paesschen W, Duncan JS, Stevens JM, Connelly A. Etiology and early prognosis of newly diagnosed partial seizures in adults: A quantitative hippocampal MRI study. Neurology 1997; 49: 753-7.
23. Arruda F, Cendes F, Anderman F, Dubeau F, Villemore J, Jones-Gotman M, et al. Mesial atrophy and outcome after amygdalohippocampectomy or temporal lobe removal. Ann Neurol 1996; 40: 446-50.
24. Lindsay J, Qunsted C, Richard P. Long-term outcome in children with temporal lobe seizures, social outcome and childhood factors. Dev Med Child Neurol 1979; 21: 285-98.
25. Kalviainen R, Salmepera T, Partanen K, Vainio P, Riekkinen P, Pitkänen A. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998; 50: 1377-80.
26. Theodore WH, Bhatia S, Hatta J, Fazilat S, De Carli X, Bookheimer SY, et al. Hippocampal atrophy, epilepsy duration and febrile seizures in patients with partial seizures. Neurology 1999; 52: 132-6.
27. Cendes F, Andermann F, Gloor P, Gambardella A, Lopes-Cendes I, Watson C, et al. Relationship between atrophy of the amygdala and ictal fear in temporal lobe epilepsy. Brain 1994; 117: 739-46.